In the temporal cortex of AD patients, GFAP+ cells were carefully quantified by co-labeling with ubiquitous astrocyte markers (glutamine synthase [GS] or aldehyde dehydrogenase 1 family, member L1). The gene discussed is GLUL; the disease is Alzheimer disease.